Nancy Lin
Nancy Lin
Dana-Farber Cancer Institute
Verified email at partners.org
Title
Cited by
Cited by
Year
Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases
PW Sperduto, N Kased, D Roberge, Z Xu, R Shanley, X Luo, PK Sneed, ...
Journal of Clinical Oncology 30 (4), 419, 2012
10752012
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
L Seymour, J Bogaerts, A Perrone, R Ford, LH Schwartz, S Mandrekar, ...
The Lancet Oncology 18 (3), e143-e152, 2017
8962017
4th ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 4)
F Cardoso, E Senkus, A Costa, E Papadopoulos, M Aapro, F André, ...
Annals of Oncology 29 (8), 1634-1657, 2018
7342018
CNS metastases in breast cancer
NU Lin, JR Bellon, EP Winer
Journal of clinical oncology 22 (17), 3608-3617, 2004
7252004
Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer
NU Lin, V Diéras, D Paul, D Lossignol, C Christodoulou, HJ Stemmler, ...
Clinical cancer research 15 (4), 1452-1459, 2009
6142009
Sites of distant recurrence and clinical outcomes in patients with metastatic triple‐negative breast cancer: high incidence of central nervous system metastases
NU Lin, E Claus, J Sohl, AR Razzak, A Arnaout, EP Winer
Cancer 113 (10), 2638-2645, 2008
5652008
Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets
PK Brastianos, SL Carter, S Santagata, DP Cahill, A Taylor-Weiner, ...
Cancer discovery 5 (11), 1164-1177, 2015
5622015
RECIST 1.1—Update and clarification: From the RECIST committee
LH Schwartz, S Litière, E De Vries, R Ford, S Gwyther, S Mandrekar, ...
European journal of cancer 62, 132-137, 2016
4882016
Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4.
E Neuman, MH Ladha, N Lin, TM Upton, SJ Miller, J DiRenzo, RG Pestell, ...
Molecular and cellular biology 17 (9), 5338-5347, 1997
4771997
Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2–positive breast cancer
NU Lin, LA Carey, MC Liu, J Younger, SE Come, M Ewend, GJ Harris, ...
Journal of clinical oncology: official journal of the American Society of …, 2008
4762008
Clinicopathologic features, patterns of recurrence, and survival among women with triple‐negative breast cancer in the National Comprehensive Cancer Network
NU Lin, A Vanderplas, ME Hughes, RL Theriault, SB Edge, YN Wong, ...
Cancer 118 (22), 5463-5472, 2012
4382012
Response assessment criteria for brain metastases: proposal from the RANO group
NU Lin, EQ Lee, H Aoyama, IJ Barani, DP Barboriak, BG Baumert, ...
The lancet oncology 16 (6), e270-e278, 2015
4192015
Brain metastases: the HER2 paradigm
NU Lin, EP Winer
Clinical Cancer Research 13 (6), 1648-1655, 2007
4112007
Systemic therapy for patients with advanced human epidermal growth factor receptor 2–positive breast cancer: American Society of Clinical Oncology clinical practice guideline
SH Giordano, S Temin, JJ Kirshner, S Chandarlapaty, JR Crews, ...
Journal of clinical oncology 32 (19), 2078, 2014
3802014
Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer
N Tung, NU Lin, J Kidd, BA Allen, N Singh, RJ Wenstrup, AR Hartman, ...
Journal of Clinical Oncology 34 (13), 1460, 2016
3012016
Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases
PW Sperduto, N Kased, D Roberge, Z Xu, R Shanley, X Luo, PK Sneed, ...
International Journal of Radiation Oncology* Biology* Physics 82 (5), 2111-2117, 2012
2942012
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
VA Adalsteinsson, G Ha, SS Freeman, AD Choudhury, DG Stover, ...
Nature communications 8 (1), 1-13, 2017
2782017
CNS metastases in breast cancer: old challenge, new frontiers
NU Lin, L Amiri-Kordestani, D Palmieri, DJ Liewehr, PS Steeg
Clinical Cancer Research 19 (23), 6404-6418, 2013
2782013
Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer
RK Murthy, S Loi, A Okines, E Paplomata, E Hamilton, SA Hurvitz, NU Lin, ...
New England Journal of Medicine 382 (7), 597-609, 2020
2682020
High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer
S Santagata, R Hu, NU Lin, ML Mendillo, LC Collins, SE Hankinson, ...
Proceedings of the National Academy of Sciences 108 (45), 18378-18383, 2011
2562011
The system can't perform the operation now. Try again later.
Articles 1–20